Investors

Significant global market opportunity

Our mission is supported by investors who represent large potential end users globally, including insurance, pharma and lab services partners with direct patient relationships.

Ativa has partnered with Honeywell to build strong patent protection around our business. We are backed by multiple Global Fortune 500 companies, with best-in-class strategic footprints in the United States and China across the blood-testing value chain. Ativa also has received a variety of grants, including recently from the U.S. Department of Defense, the National Institutes of Health (NIH) and Massachusetts General Hospital.

Efficient patient interactions can increase satisfaction and lead to economic wins both for care providers and insurers. Beyond the bottom line motivation to implement this technology, we believe it has the potential to deliver better outcomes and convenience for the benefit of patients.


Are you interested in joining us? Contact us to learn more.